通过自组装纳米颗粒进行增强的氧化输送,用于消灭阴性细菌
Xiangfeng Lai1, Lei Yu2, Xiangyi Huang1
1Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Clayton, Victoria, 3800, Australia.
Advanced healthcare materials
|September 12, 2024
概括
新的氧化 (NO) 供体纳米颗粒 (FuNPs) 与多素B (PMB) 结合,显示出对抗性格兰氏阴性细菌增强的杀菌作用. 这一创新策略有效地克服了抗生素耐药性的障碍.
科学领域:
- 抗微生物耐药性研究的研究.
- 纳米技术在医学中的应用
- 细菌膜相互作用的相互作用
背景情况:
- 格拉姆阴性细菌具有保护性的外膜和排泄,有助于抗生素耐药性.
- 迫切需要新的战略来应对抗微生物药物耐药性日益增长的威胁.
研究的目的:
- 开发和评估用于增强抗菌活性的新型氧化 (NO) 供体纳米粒子 (FuNPs).
- 调查FuNPs与聚米辛B (PMB) 结合的协同杀菌机制.
主要方法:
- 合成了三种用于自组装成NO捐赠纳米颗粒 (FuNPs) 的furoxan衍生物.
- 对FUNP和PMB对格兰氏阴性细菌的杀菌功效的评估.
- 使用共聚焦,扫描和传输电子显微镜以及中子反射计来阐明机制.
主要成果:
- 与PMB结合的FuNPs在低NO度 (0.1-2.8μg mL-1) 中显著增强了杀菌效果.
- 观察到,FuNPs通过与表面多糖相互作用来破坏细菌外膜.
- 通过与脂质A结合,PMB增强了外膜的透性,从而导致协同杀死细菌.
结论:
- 自组装的NO-捐赠纳米颗粒提供了一种有前途的策略,以克服格兰负细菌的抗生素耐药性.
- NP和PMB的组合代表了下一代抗菌剂的突破性方法.
更多相关视频
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
946
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
12.8K
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
01:18Drug Delivery: Enteral Route
394
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
394